High-quality , affordable generic products with excellent service

Viona Pharmaceuticals is an emerging generic pharmaceutical company established in May 2018 and located in Cranford, NJ. Viona is a wholly owned indirect subsidiary of Cadila Healthcare Limited located in India. Viona has already launched a range of products in 2019 and has a vast number of generic pharmaceutical products in the pipeline, which we are excited to introduce to the market in due course of time! Viona is currently marketing and distributing a range of Oral Solids and has plans in place to launch a range of Topicals in 2020. To see the products which we have already introduced into the market, please see our products list.

Viona has built a team of experienced and committed professionals in all aspects of the business and we have ambitious growth plans for our company.

Our mission is to provide our customers with high quality, affordable generic products with an excellent service level.


May 2018

Viona Incorporated

May 2019

Viona launches Metronidazole Tablets, USP 250mg & 500mg

July 2019

Viona launches Voriconazole Tablets 50mg & 200mg

September 2019

Viona Launches Doxycycline Hyclate Tablets, USP 100mg

December 2019

Viona Launches Memantine Hydrochloride Tablets, USP 5mg & 10mg and Metformin Hydrochloride Tablets Extended-Release Tablets, USP 750mg

January 2020

Viona launches Ranolazine Extended-Release Tablets 500mg & 1,000mg

July 2020

Viona Launches Acyclovir Ointment, USP 5% and Desonide Cream 0.05%

September 2020

Viona Launches Betamethasone Dipropionate Ointment, USP 0.05% and Fluocinonide Cream, USP 0.1%

October 2020

Viona Launches Nystatin Ointment, USP

November 2020

Viona Launches Desoximetasone Ointment, USP